Metraipolis › archive › dc_644f60ea628e

PD-L1 Expression and Histopathological Features in EGFR-Mutated Non-Small Cell Lung Cancer: Implications for Immune Checkpoint Inhibitors After EGFR-Tyrosine… — Europe PMC PMID:41663093

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41663093
DOI: 10.1111/1759-7714.70252
License (as archived): solo-consultazione
Archived: 2026-11-06T08:47:12.228Z
SHA-256 of the archived text: a0585e8856dafb6015ecfc6658dfa9058aec531599091389414e9be05db11573
Stable URL of this page: https://metraipolis.com/documento/dc_644f60ea628e

How to cite

PD-L1 Expression and Histopathological Features in EGFR-Mutated Non-Small Cell Lung Cancer: Implications for Immune Checkpoint Inhibitors After EGFR-Tyrosine… — Europe PMC PMID:41663093 — Europe PMC (en), https://europepmc.org/article/MED/41663093 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_644f60ea628e (Metraipolis archive dc_644f60ea628e, sha256 a0585e8856dafb6015ecfc6658dfa9058aec531599091389414e9be05db11573)

BibTeX

@misc{dc644f60ea628e,
  title = {PD-L1 Expression and Histopathological Features in EGFR-Mutated Non-Small Cell Lung Cancer: Implications for Immune Checkpoint Inhibitors After EGFR-Tyrosine… — Europe PMC PMID:41663093},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41663093},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_644f60ea628e; sha256 a0585e8856dafb6015ecfc6658dfa9058aec531599091389414e9be05db11573},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41663093. Agents can read the archived copy with the MCP tool read_document.